Our Pathbreaking Work and Tradition of Service

D. Ziedonis, MD, MPHWith our clinical work, education programs and world-class research on the nature and causes of mental illness – from addiction and schizophrenia to autism spectrum disorders – the UMass Department of Psychiatry is helping individuals and families transform their lives. We are proud of our accomplishments and pleased to be a part of the nationally ranked University of Massachusetts Medical School and UMass Memorial Health Care system.

  • The department's "bench to bedside" and "bedside to community" research focuses on treatment and prevention.
  • Our training programs and approach to mentoring promote excellence in teaching for future mental health care practitioners.
  • Our products and services reach across the Commonwealth of Massachusetts and, now, are found in numerous sites internationally.
  • Our more than 300 faculty and 2,000 staff members work in many settings within the Medical School and UMass Memorial Health Care, the public sector, and the community at large.

Douglas M. Ziedonis MD, MPH
Professor and Chairman, Department of Psychiatry
UMass Medical School/UMass Memorial Medical Center
President, UMass Memorial Behavioral Health Services
Professor, Graduate School of Nursing & Graduate School of Biomedical Sciences

Latest Psychiatry Department News

Symposium addresses Syrian refugee crisis
Hussam Jefee-Bahloul, MD, UMass Medical School assistant professor of psychiatry, took to the podium to address the effects of armed conflict on mental health in Syrian refugees at the University of Buffalo's "Syrian Refugees: Buffalo Responds" public symposium. He noted that the majority of mental health manifestations in Syrian refugees are related to either exacerbations of pre-existing mental disorders, or prompted by conflict-related violence and displacement. Read more.
   
UMMS tobacco prevention experts encouraged by FDA regulations on e-cigarettes
Tobacco prevention and treatment experts at UMass Medical School are applauding the U.S. Food and Drug Administration's historic decision to extend its authority to all tobacco products, including e-cigarettes. The rule prohibits sale of tobacco products to anyone under the age of 18. Read more in UMassMedNow.
   
New grant to help teens with psychiatric disabilities become successful adults
The transition from teenage years to adulthood is challenging for many young people, but it is far more difficult for people with psychiatric disabilities. Read more on this story in UMassMedNow.

More in the news...

Spotlight

Can a genetic test help predict which antidepressant will be most effective?

Clinical trial seeks to reduce trial-and-error prescribing for patients with depression. 

Rothschild

By Sandra Gray
UMass Medical School Communications
Depression is the most commonly diagnosed mental illness, and antidepressants are the most frequently prescribed treatments for it. But with dozens of medications to choose from, and with individuals responding better to some drugs than to others—possibly due to genetic differences that affect how the medications are metabolized and how they act on the brain—patients must often try several medications before finding one that is most effective.

"It's a lot of trial and error even for those of us who are experts, and most antidepressants are prescribed by primary care physicians, not psychiatrists," said UMass Medical School psychiatrist Anthony Rothschild, MD, the Irving S. and Betty Brudnick Chair in Psychiatry, professor of psychiatry and director of the Center for Psychopharmacologic Research and Treatment at UMMS.
Read more... 

▴ Back To Top
Section Menu To Top